ERBIN:: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor

被引:256
|
作者
Borg, JP
Marchetto, S
Le Bivic, A
Ollendorff, V
Jaulin-Bastard, F
Saito, H
Fournier, E
Adélaïde, J
Margolis, B
Birnbaum, D
机构
[1] INSERM, U119, F-13009 Marseille, France
[2] Fac Sci Luminy, IBDM, F-13288 Marseille 09, France
[3] Inst J Paoli I Calmettes, F-13009 Marseille, France
[4] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA
关键词
D O I
10.1038/35017038
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The ERBB receptors have a crucial role in morphogenesis and oncogenesis. We have identified a new PDZ protein we named ERBIN (ERBB2 interacting protein) that acts as an adaptor for the receptor ERBB2/HER2 in epithelia. ERBIN contains 16 leucine-rich repeats (LRRs) in its amino terminus and a PDZ (PSD-95/DLG/ZO-1) domain at its carboxy terminus, and belongs to a new PDZ protein family. The PDZ domain directly and specifically interacts with ERBB2/ HER2. ERBIN and ERBB2/HER2 colocalize to the lateral membrane of human intestinal epithelial cells. The ERBIN-binding site in ERBB2/HER2 has a critical role in restricting this receptor to the basolateral membrane of epithelial cells, as mutation of the ERBIN-binding site leads to the mislocalization of the receptor in these cells. We suggest that ERBIN acts in the localization and signalling of ERBB2/HER2 in epithelia.
引用
收藏
页码:407 / 414
页数:8
相关论文
共 50 条
  • [1] ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor
    Jean-Paul Borg
    Sylvie Marchetto
    André Le Bivic
    Vincent Ollendorff
    Fanny Jaulin-Bastard
    Hiroko Saito
    Emmanuel Fournier
    José Adélaïde
    Ben Margolis
    Daniel Birnbaum
    Nature Cell Biology, 2000, 2 : 407 - 414
  • [2] The ERBB2/HER2 receptor differentially interacts with ERBIN and PICK1PSD-95/DLG/ZO-1 domain proteins
    Jaulin-Bastard, F
    Saito, H
    Le Bivic, A
    Ollendorff, V
    Marchetto, S
    Birnbaum, D
    Borg, JP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) : 15256 - 15263
  • [3] ERBB2 (HER2) protein expression in uterine sarcomas
    Zafrakas, M.
    Zepiridis, L.
    Theodoridis, T. D.
    Venizelos, I. D.
    Papanicolaou, A.
    Agorastos, T.
    Bontis, J. N.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2009, 30 (03) : 292 - 294
  • [4] The ErbB2/Neu/HER2 receptor is a new calmodulin-binding protein
    Li, HB
    Sánchez-Torres, J
    del Carpio, A
    Salas, V
    Villalobo, A
    BIOCHEMICAL JOURNAL, 2004, 381 : 257 - 266
  • [5] ErbB2/HER2/Neu resembles an autoinhibited invertebrate EGF receptor
    Alvarado, Diego
    Klein, Daryl E.
    Lemmon, Mark A.
    FASEB JOURNAL, 2009, 23
  • [6] HER2/ERBB2 immunoreactivity in human retinoblastoma
    Seigel, G. M.
    Sharma, S.
    Hackam, A. S.
    Shah, Dhaval K.
    TUMOR BIOLOGY, 2016, 37 (05) : 6135 - 6142
  • [7] ERBB2 (HER2) Testing in Breast Cancer
    Hilal, Talal
    Romond, Edward H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (12): : 1280 - 1281
  • [8] The Mysterious Ways of ErbB2/HER2 Trafficking
    Bertelsen, Vibeke
    Stang, Espen
    MEMBRANES, 2014, 4 (03): : 424 - 446
  • [9] ERBB2 (HER2) Gene Amplification and Protein Overexpression in Ampullary Carcinoma
    Hechtman, Jaclyn
    Arcila, Maria
    Vakiani, Efsevia
    Shia, Jinru
    Klimstra, David
    MODERN PATHOLOGY, 2015, 28 : 165A - 165A
  • [10] ERBB2 (HER2) Gene Amplification and Protein Overexpression in Ampullary Carcinoma
    Hechtman, Jaclyn
    Arcila, Maria
    Vakiani, Efsevia
    Shia, Jinru
    Klimstra, David
    LABORATORY INVESTIGATION, 2015, 95 : 165A - 165A